Simultaneous quantification of donafenib, sorafenib, and their N-oxide metabolites in rat plasma using a HPLC-MS/MS method
- 4 September 2023
- journal article
- research article
- Published by Elsevier in Journal of Chromatography B
- Vol. 1229, 123871
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82003189, 82204445)
- Natural Science Foundation of Zhejiang Province (LYQ20H310001, LYY21H310011)
- Chinese Medicine Research Program of Zhejiang Province (2021ZZ001, 2022ZB017)
This publication has 20 references indexed in Scilit:
- A global view of hepatocellular carcinoma: trends, risk, prevention and managementNature Reviews Gastroenterology & Hepatology, 2019
- Impact of Deuterium Substitution on the Pharmacokinetics of PharmaceuticalsAnnals of Pharmacotherapy, 2018
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinomaJournal of Hepatology, 2018
- A sensitive LC–MS/MS method for simultaneous determination of cabozantinib and its metabolite cabozantinib N‐oxide in rat plasma and its application in a pharmacokinetic studyBiomedical Chromatography, 2018
- Development and validation of a sensitive LC–MS/MS method for simultaneous determination of eight tyrosine kinase inhibitors and its application in mice pharmacokinetic studiesJournal of Pharmaceutical and Biomedical Analysis, 2017
- Simultaneous analysis of regorafenib and sorafenib and three of their metabolites in human plasma using LC–MS/MSJournal of Pharmaceutical and Biomedical Analysis, 2017
- An LC–MS/MS method for rapid and sensitive high‐throughput simultaneous determination of various protein kinase inhibitors in human plasmaBiomedical Chromatography, 2016
- A Quantitative HPLC-UV Method for Determination of Serum Sorafenib and Sorafenib N-Oxide and Its Application in Hepatocarcinoma PatientsThe Tohoku Journal of Experimental Medicine, 2014
- Role of human CYP3A4 in the biotransformation of sorafenib to its major oxidized metabolitesBiochemical Pharmacology, 2012
- Quantitation of sorafenib and its active metabolite sorafenib N-oxide in human plasma by liquid chromatography–tandem mass spectrometryJournal of Chromatography B, 2010